Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59.23 USD | -1.51% | -2.10% | -29.06% |
May. 22 | Cytokinetics, Royalty Pharma Unveil up to $575 Million Funding to Advance Research Pipeline | MT |
May. 22 | Cytokinetics Plans $500 Million Common Stock Offering -- Shares Drop After Hours | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Bullish |
Resistance | 63.75 | 108.06 | 93.73 |
Spread/Res. | -7.09% | -45.19% | -36.81% |
Spread/Supp. | +3.37% | +3.37% | +14.30% |
Support | 57.30 | 57.30 | 51.82 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CYTK Stock
- Charts Cytokinetics, Incorporated